Comparison of Hospitalization Costs Associated With Human Metapneumovirus and Respiratory Syncytial Virus Infection in US Adults.
Saved in:
| Title: | Comparison of Hospitalization Costs Associated With Human Metapneumovirus and Respiratory Syncytial Virus Infection in US Adults. |
|---|---|
| Authors: | Ackerson BK; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Rayens E; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Sy LS; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Tseng HF; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Qian L; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Luo Y; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Juan R; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Huang X; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Ku JH; Center for Integrated Health Care Research, Kaiser Permanente, Honolulu, Hawaii, USA., Modha PP; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Bathala RM; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Venkatesan S; BPM Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK., Glasser L; Vaccines and Immune Therapies, AstraZeneca, Wilmington, Delaware, USA., McNulty R; Vaccines and Immune Therapies, AstraZeneca, Cambridge, UK., Molnar D; Vaccines and Immune Therapies, AstraZeneca, Barcelona, Spain., Wang C; Vaccines and Immune Therapies, AstraZeneca, Gaithersburg, Maryland, USA., An J; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA. |
| Source: | Open forum infectious diseases [Open Forum Infect Dis] 2026 Apr 02; Vol. 13 (4), pp. ofag202. Date of Electronic Publication: 2026 Apr 02 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2328-8957 |
|---|---|
| DOI: | 10.1093/ofid/ofag202 |
